ArticleClinical and public health guidelines2026
EAES Clinical Practice Guideline 2026 Protocol: Multi-Society Recommendations for the Treatment of Achalasia.
Article in Clinical and public health guidelines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Achalasia causes significant distress and quality-of-life impairment to patients. Several options exist for the treatment of achalasia including endoscopic [intra-sphincteric injection of botulinum toxin, pneumatic dilation, peroral endoscopic myotomy (POEM)], and surgical techniques such as Heller Myotomy. Methods: This guideline will adhere to robust methodological standards according to GIN, GRADE, and AGREE-S. We will develop a clinical practice guideline addressing the treatment of patients with achalasia. A systematic review group will perform an evidence synthesis and network meta-analysis before appraising the certainty of evidence. An international, multidisciplinary panel will review the evidence and develop recommendations using the evidence-to-decision framework. The panel will be comprised of gastroenterologists, gastrointestinal surgeons, and patient partners. We will collect and address conflicts of interest for all guideline development group members. We will present this clinical practice guideline at international congresses and publish in the Journal of Questions: We will conduct a clinical practice guideline to provide evidence-informed treatment recommendations for patients with achalasia. We will examine the following questions:In patients with type I achalasia, what is the relative impact of Botox injection versus pneumatic dilation versus POEM versus Heller myotomy alone versus Heller myotomy with fundoplication on patient-important outcomes?In patients with type II achalasia, what is the relative impact of Botox injection versus pneumatic dilation versus POEM versus Heller myotomy alone versus Heller myotomy with fundoplication on patient-important outcomes?In patients with type III achalasia, what is the relative impact of Botox injection versus pneumatic dilation versus POEM versus Heller myotomy alone versus Heller myotomy with fundoplication on patient-important outcomes?
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.